Helix Funding & Investors
Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+™ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.
helix.comTotal Amount Raised: $403,000,000
Helix Funding Rounds
Series C
$50,000,000
Series C Investors
Warburg PincusMayo Clinic VenturesKleiner Perkins Caufield & ByersTemasekDFJ GrowthSeries B
$200,000,000
Series B Investors
DFJ GrowthWarburg PincusIlluminaKleiner Perkins Caufield & ByersMayo ClinicSutter Hill VenturesTemasekGrant
$33,000,000
Grant Investors
National Institutes of Health (NIH)Series Unknown
$20,000,000
Series Unknown Investors
Kleiner Perkins Caufield & ByersCasdin CapitalSeries A
$100,000,000
Series A Investors
IlluminaWarburg PincusSutter Hill VenturesLaunchCapitalMayo Clinic
Funding info provided by Diffbot.